TFRC and acute myeloid leukemia: Since AML cells exhibit high expression levels of the TFRC, we hypothesized that Ara-C would be delivered into AML cells with higher efficiency through Ara-C@HFn to inhibit AML cell development (Fig. 3a) more efficiently.